Foghorn Therapeutics  logo
Foghorn Therapeutics FHTX
€ 1.56 -4.47%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 09.11.2026

Foghorn Therapeutics Langfristige Verbindlichkeiten | FHTX

Langfristige Verbindlichkeiten Jährlich Foghorn Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
247 M 263 M 305 M 350 M 374 M 90.6 M 97.7 M 78.9 M - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
374 M 78.9 M 226 M

Langfristige Verbindlichkeiten Vierteljährlich Foghorn Therapeutics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
168 M 234 M 234 M 247 M 210 M 225 M 249 M 263 M 280 M 292 M 300 M 305 M 319 M 332 M 342 M 350 M 354 M 361 M 368 M 374 M 85.8 M 87.9 M 88.4 M 90.6 M 78 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
374 M 78 M 249 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Langfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Repare Therapeutics Repare Therapeutics
RPTX
59.2 M - - $ 112 M canadaCanada
Sesen Bio Sesen Bio
SESN
42.3 M - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
37.2 M - - $ 26.8 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
58.7 M - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
75.8 M - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
65.4 K - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
541 M - - - russiaRussia
Lyra Therapeutics Lyra Therapeutics
LYRA
1.45 M - - $ 24.9 M usaUSA
Brickell Biotech Brickell Biotech
BBI
146 K - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
2.39 M - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
127 K - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
132 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
4.72 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
95.3 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
2.22 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
23.3 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
612 K - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
27.9 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
17.8 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
2 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
2.03 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
44 K $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
11.2 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
5.12 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
6 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
35.2 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
615 K - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
10.9 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
806 M - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
743 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
1.93 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
127 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
36 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
227 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
12.6 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
272 K - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
18.7 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
12 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
234 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
477 K - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
1.93 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
15 M - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
996 K - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
25.2 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
9.13 M - 31.87 % $ 1.61 M usaUSA